Dr. Ziai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080
Education & Training
- Yale-New Haven Medical CenterFellowship, Molecular Genetic Pathology, 2011 - 2013
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematopathology, 2010 - 2011
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- Rutgers New Jersey Medical SchoolClass of 2006
Certifications & Licensure
- CA State Medical License 2010 - 2025
- CT State Medical License 2011 - 2013
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Hematology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Correction to: Preclinical development of ZED8, anZr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.Annie Ogasawara, James R Kiefer, Herman Gill, Eugene Chiang, Shravan Sriraman
European Journal of Nuclear Medicine and Molecular Imaging. 2023-01-01 - 1 citationsMass Spectrometry-Based Tissue Imaging of the Tumor Microenvironment.Tyler Risom, Patrick Chang, Sandra Rost, James Ziai
Methods in Molecular Biology. 2023-01-01 - 4 citationsPreclinical development of ZED8, anZr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.Annie Ogasawara, James R Kiefer, Herman Gill, Eugene Chiang, Shravan Sriraman
European Journal of Nuclear Medicine and Molecular Imaging. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: